Back to search

Article

Directed evolution-based discovery of ligands for in vivo restimulation of CAR-T cells

2024-04-17

Abstract excerpt

Chimeric antigen receptor (CAR) T cell therapy targeting CD19 elicits remarkable clinical efficacy in B-cell malignancies, but many patients relapse due to failed expansion and/or progressive loss of CAR-T cells. We recently reported a strategy to potently restimulate CAR-T cells in vivo , enhancing their functionality by administration of a vaccine-like stimulus comprised of surrogate peptide ligands for a CAR l...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f3ca3b36-6866-51cc-88cc-a24b94562a6a
DOI
10.1101/2024.04.16.589780
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Directed evolution-based discovery of ligands for in vivo restimulation of CAR-T cellsDOI 10.1101/2024.04.16.589780
Select a neighboring publication to make it the new centre.